NASDAQ NMS - GLOBAL MARKET · CLNN
+1.89% · +$0.1000 · Vol 46.5K
After hours · updated 16:00:00 ET
Clene Inc

Clene Inc

Biotechnology
$5.38
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
CLNN
Clene Inc
Tue Aug 4 · last completed session · Markets closed · resumes Thu 9:30 ET
AVOID

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

27/ 100
Veridion Score
AVOID · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Tue Aug 4 · last completed session · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CLNN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CLNN catalysts
About Clene Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
79
Country
US

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.40
Day high
$5.48
Day low
$5.26
Previous close
$5.28
52W high
$12.50
-56.96% from high
52W low
$3.60
20% of range
Market cap
$67.5M
EPS
$-0.6900
Beta
1.39
Shares out
12.8M
Volume
46.5K
0.74× rel vol
Avg volume
62.5K
VWAP
$5.37
Price history computed in-house
1W
+13.98%
1M
-10.48%
3M
-27.20%
1Y
+45.80%
YTD
-8.35%
SMA 50 $5.85 · below
SMA 200 $6.35 · below
52W position 20%

CLNN overview

Veridion Score
27
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CLNN.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CLNN Form 4 filings
Public disclosures

Congress activity in CLNN

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CLNN in the cached public ledger.

Federal contracts

CLNN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CLNN in this window.
Lobbying spend

CLNN lobbying filings, year to date.

Registered lobbying filings matched to Clene Inc.

$160.0K
Refresh interval: 12hSource: LDA disclosure filings
Energy/NuclearHealth Issues
Filing
$60.0K
CLENERA LLC

LOT SIXTEEN LLC

Jul 17, 2026
Filing
$60.0K
CLENERA LLC

LOT SIXTEEN LLC

Apr 20, 2026
Filing
$20.0K
CLENE NANOMEDICINE

CAPITOL HILL CONSULTING GROUP

Jan 20, 2026
Loading news for CLNN
Analyst ratings
Sovereign unlock shows live analyst consensus for CLNN.
Options
Sovereign unlock shows live options positioning for CLNN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.